» Articles » PMID: 23991509

Bringing Central Line-associated Bloodstream Infection Prevention Home: CLABSI Definitions and Prevention Policies in Home Health Care Agencies

Overview
Publisher Elsevier
Specialty Health Services
Date 2013 Sep 3
PMID 23991509
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A study was conducted to investigate health care agency central line-associated bloodstream infection (CLABSI) definitions and prevention policies and pare them to the Joint Commission National Patient Safety Goal (NPSG.07.04.01), the Centers for Disease Control and Prevention (CDC) CLABSI prevention recommendations, and a best-practice central line care bundle for inpatients.

Methods: A telephone-based survey was conducted in 2011 of a convenience sample of home health care agencies associated with children's hematology/oncology centers.

Results: Of the 97 eligible home health care agencies, 57 (59%) completed the survey. No agency reported using all five aspects of the National Healthcare and Safety Network/Association for Professionals in Infection Control and Epidemiology CLABSI definition and adjudication process, and of the 50 agencies that reported tracking CLABSI rates, 20 (40%) reported using none. Only 10 agencies (18%) had policies consistent with all elements of the inpatient-focused NPSG.07.04.01, 10 agencies (18%) were consistent with all elements of the home care targeted CDC CLABSI prevention recommendations, and no agencies were consistent with all elements of the central line care bundle. Only 14 agencies (25%) knew their overall CLABSI rate: mean 0.40 CLABSIs per 1,000 central line days (95% confidence interval [CI], 0.18 to 0.61). Six agencies (11%) knew their agency's pediatric CLABSI rate: mean 0.54 CLABSIs per 1,000 central line days (95% CI, 0.06 to 1.01).

Conclusions: The policies of a national sample of home health care agencies varied significantly from national inpatient and home health care agency targeted standards for CLABSI definitions and prevention. Future research should assess strategies for standardizing home health care practices consistent with evidence-based recommendations.

Citing Articles

Controlling the chaos: Information management in home-infusion central-line-associated bloodstream infection (CLABSI) surveillance.

Hannum S, Oladapo-Shittu O, Salinas A, Weems K, Marsteller J, Gurses A Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e69.

PMID: 37113198 PMC: 10127240. DOI: 10.1017/ash.2023.134.


Implementing and validating a home-infusion central-line-associated bloodstream infection surveillance definition.

Keller S, Hannum S, Weems K, Oladapo-Shittu O, Salinas A, Marsteller J Infect Control Hosp Epidemiol. 2023; 44(11):1748-1759.

PMID: 37078467 PMC: 10665867. DOI: 10.1017/ice.2023.70.


Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.

Kelada A, Foster T, Gagliano G, Worley S, Tang A, Arakoni V Infect Control Hosp Epidemiol. 2022; 44(3):377-383.

PMID: 35475427 PMC: 10015264. DOI: 10.1017/ice.2022.91.


Perspectives on central-line-associated bloodstream infection surveillance in home infusion therapy.

Keller S, Alexander M, Williams D, Rock C, Han J, Schweizer M Infect Control Hosp Epidemiol. 2019; 40(6):729-731.

PMID: 31014410 PMC: 6903682. DOI: 10.1017/ice.2019.90.


A new frontier: Central line-associated bloodstream infection surveillance in home infusion therapy.

Keller S, Williams D, Rock C, Deol S, Trexler P, Cosgrove S Am J Infect Control. 2018; 46(12):1419-1421.

PMID: 29908838 PMC: 6329378. DOI: 10.1016/j.ajic.2018.05.016.


References
1.
Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S . An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006; 355(26):2725-32. DOI: 10.1056/NEJMoa061115. View

2.
Advani S, Reich N, Sengupta A, Gosey L, Milstone A . Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis. 2011; 52(9):1108-1115. PMC: 3070870. DOI: 10.1093/cid/cir145. View

3.
Miller M, Niedner M, Huskins W, Colantuoni E, Yenokyan G, Moss M . Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics. 2011; 128(5):e1077-83. DOI: 10.1542/peds.2010-3675. View

4.
Miller M, Griswold M, Mitchell Harris 2nd J, Yenokyan G, Huskins W, Moss M . Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics. 2010; 125(2):206-13. DOI: 10.1542/peds.2009-1382. View

5.
Castello F, Maher A, Cable G . Reducing bloodstream infections in pediatric rehabilitation patients receiving parenteral nutrition. Pediatrics. 2011; 128(5):e1273-8. DOI: 10.1542/peds.2010-3617. View